Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
2010 1
2011 2
2012 1
2013 3
2014 4
2015 3
2016 2
2017 5
2018 3
2019 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Vitamin K and osteoporosis: Myth or reality?
Palermo A, Tuccinardi D, D'Onofrio L, Watanabe M, Maggi D, Maurizi AR, Greto V, Buzzetti R, Napoli N, Pozzilli P, Manfrini S. Palermo A, et al. Among authors: maurizi ar. Metabolism. 2017 May;70:57-71. doi: 10.1016/j.metabol.2017.01.032. Epub 2017 Feb 4. Metabolism. 2017. PMID: 28403946 Review.
Prevention of type 2 diabetes mellitus: is it feasible?
Palermo A, Maggi D, Maurizi AR, Pozzilli P, Buzzetti R. Palermo A, et al. Among authors: maurizi ar. Diabetes Metab Res Rev. 2014 Mar;30 Suppl 1:4-12. doi: 10.1002/dmrr.2513. Diabetes Metab Res Rev. 2014. PMID: 24353270 Review.
Diabetes on demand and novel technologies.
Maurizi AR, Piemonte V, Pozzilli P. Maurizi AR, et al. Diabetes Metab Res Rev. 2018 Feb;34(2). doi: 10.1002/dmrr.2985. Diabetes Metab Res Rev. 2018. PMID: 29377511
Ladarixin, an inhibitor of the interleukin-8 receptors CXCR1 and CXCR2, in new-onset type 1 diabetes: A multicentre, randomized, double-blind, placebo-controlled trial.
Piemonti L, Keymeulen B, Gillard P, Linn T, Bosi E, Rose L, Pozzilli P, Giorgino F, Cossu E, Daffonchio L, Goisis G, Ruffini PA, Maurizi AR, Mantelli F, Allegretti M. Piemonti L, et al. Among authors: maurizi ar. Diabetes Obes Metab. 2022 Sep;24(9):1840-1849. doi: 10.1111/dom.14770. Epub 2022 Jul 4. Diabetes Obes Metab. 2022. PMID: 35589610 Free PMC article. Clinical Trial.
Risk factors for fragility fractures in type 1 diabetes.
Leanza G, Maddaloni E, Pitocco D, Conte C, Palermo A, Maurizi AR, Pantano AL, Suraci C, Altomare M, Strollo R, Manfrini S, Pozzilli P, Schwartz AV, Napoli N. Leanza G, et al. Among authors: maurizi ar. Bone. 2019 Aug;125:194-199. doi: 10.1016/j.bone.2019.04.017. Epub 2019 May 3. Bone. 2019. PMID: 31059862
Diabetes-related autoantibodies in children with acute lymphoblastic leukemia.
Bizzarri C, Pinto RM, Pitocco D, Astorri E, Cappa M, Hawa M, Giannone G, Palermo A, Maddaloni E, Leslie DR, Pozzilli P; IMDIAB Group. Bizzarri C, et al. Diabetes Care. 2012 Mar;35(3):e23. doi: 10.2337/dc11-1946. Diabetes Care. 2012. PMID: 22355026 Free PMC article. No abstract available.
Continuous subcutaneous insulin infusion in Italy: third national survey.
Bruttomesso D, Laviola L, Lepore G, Bonfanti R, Bozzetto L, Corsi A, Di Blasi V, Girelli A, Grassi G, Iafusco D, Rabbone I, Schiaffini R; Italian Study Group on Diffusion of CSII. Bruttomesso D, et al. Diabetes Technol Ther. 2015 Feb;17(2):96-104. doi: 10.1089/dia.2014.0242. Epub 2014 Dec 5. Diabetes Technol Ther. 2015. PMID: 25479035 Free article.
A novel insulin unit calculator for the management of type 1 diabetes.
Maurizi AR, Lauria A, Maggi D, Palermo A, Fioriti E, Manfrini S, Pozzilli P. Maurizi AR, et al. Diabetes Technol Ther. 2011 Apr;13(4):425-8. doi: 10.1089/dia.2010.0190. Epub 2011 Feb 28. Diabetes Technol Ther. 2011. PMID: 21355727 Clinical Trial.
23 results